BNP-32 (human)

CAS : 124584-08-3

Ref. 01-4016567

Informations sur le produit

• Nom: BNP-32 (human)
• Synonymes: Nesiritide, Natriureticfactor-32 (human brain clone lhBNP57), 1,2-Dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane,cyclic peptide deriv., 1: PN:US6028055 SEQID: 1 claimed protein, 6: PN:US20090011997 SEQID: 4 claimed protein, 83: PN: US20080153747 SEQID: 83 claimedprotein, Human brain natriuretic factor-32, Human brain natriuretic peptide-32, L-Histidine,L-seryl-L-prolyl-L-lysyl-L-methionyl-L-valyl-L-glutaminylglycyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-lysyl-L-methionyl-L-a-aspartyl-L-arginyl-L-isoleucyl-L-seryl-L-seryl-L-seryl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-lysyl-L-valyl-L-leucyl-L-arginyl-L-arginyl-,cyclic (10?, 26)-Disulfide, Natriureticpeptide type-B
• CAS: 124584-08-3

Description

The secretion of the cardiac hormone BNP-32 is increased considerably in patients with congestive heart failure, successful medical treatment of this condition will result in a decrease. Yandle et al. described a method for determining hBNP in human plasma. Effects of hBNP infusion in humans have been described by Holmes et al and La Villa et al. BNP is an important biomarker in the diagnosis of heart diseases. Additionally, BNP-32 may act as a neuropeptide. BNP-32 exerts strong lipolytic effects in humans.

• Marque: Bachem

Propriétés chimiques

• Masse moléculaire: 3464.09
• Formule: C₁₄₃H₂₄₄N₅₀O₄₂S₄
• Degré de pureté: 97.2%
• Couleur/Forme: White